These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2504600)

  • 21. [Bacteriological, pharmacokinetic and clinical studies of 5% and 10% granules of cefdinir in the pediatric field].
    Toyonaga Y; Hatakeyama K; Yamori K; Sakaguchi N; Nakano K; Yamazaki M; Sugita M; Hori M
    Jpn J Antibiot; 1992 Jan; 45(1):48-73. PubMed ID: 1495196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Penetration of cefixime into fibrin clots and in vivo efficacy against Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus.
    Bergeron MG; Turcotte A
    Antimicrob Agents Chemother; 1986 Dec; 30(6):913-6. PubMed ID: 3545070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parameters characterizing the in vitro activity of cefixime, a new oral broad spectrum cephalosporin, against respiratory and urinary pathogens.
    Debbia EA; Marchese A; Pesce A; Saverino D; Schito GC
    J Chemother; 1992 Jun; 4(3):131-44. PubMed ID: 1517806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of cefixime and six other agents against nosocomial pathogens of the Enterobacteriaceae family.
    Mulligan ME
    Infect Control; 1987 Jun; 8(6):241-4. PubMed ID: 3498702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro antibacterial activity of cefixime.
    Lin SR; Peng CF
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1988 Oct; 4(10):586-91. PubMed ID: 3230604
    [No Abstract]   [Full Text] [Related]  

  • 26. Double-blind comparison of cefixime and cefaclor in the treatment of acute otitis media in children.
    Piippo T; Stefansson S; Pitkäjärvi T; Lundberg C
    Scand J Infect Dis; 1991; 23(4):459-65. PubMed ID: 1957129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of cefixime versus cefaclor in respiratory tract infections.
    Dorow P
    J Chemother; 1989 Aug; 1(4):257-60. PubMed ID: 2809693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cefixime, in-vitro activity, pharmacokinetics and tissue penetration.
    Stone JW; Linong G; Andrews JM; Wise R
    J Antimicrob Chemother; 1989 Feb; 23(2):221-8. PubMed ID: 2708180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility of respiratory tract pathogens in Finland to cefixime and nine other antimicrobial agents.
    Lehtonen L; Huovinen P
    Scand J Infect Dis; 1993; 25(3):373-8. PubMed ID: 8362234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bacteriological in vitro investigations with cefaclor. Correlation of inhibition zone diameter and minimal inhibitory concentration (author's transl)].
    Grimm H
    Infection; 1979; 7 Suppl 6():540-2. PubMed ID: 399245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibacterial activity of the investigational oral and parenteral cephalosporin BK-218.
    Johnson DM; Jones RN
    Eur J Clin Microbiol Infect Dis; 1992 Feb; 11(2):181-8. PubMed ID: 1396735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibacterial activity of cefixime against Streptococcus pneumoniae, Streptococcus pyogenes, and Haemophilus influenzae in the presence of Moraxella (Branhamella) catarrhalis.
    Yamada T; Yokota Y; Ikeda F; Mine Y; Kitada T
    Chemotherapy; 1992; 38(1):28-35. PubMed ID: 1618001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of in vitro antibacterial activity of four oral cephems: cephalexin, cefaclor, cefatrizine and cefadroxil.
    Luh KT; Chao HP; Ho SW; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1984 Feb; 17(1):11-8. PubMed ID: 6378550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Summary of laboratory studies on the antibacterial activity of cefaclor.
    Preston DA
    Postgrad Med J; 1979; 55 Suppl 4():22-9. PubMed ID: 398479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liquid-chromatographic determination of five orally active cephalosporins--cefixime, cefaclor, cefadroxil, cephalexin, and cephradine--in human serum.
    McAteer JA; Hiltke MF; Silber BM; Faulkner RD
    Clin Chem; 1987 Oct; 33(10):1788-90. PubMed ID: 3665031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of sinus empyema in adults. A coordinated Nordic multicenter trial of cefixime vs. cefaclor.
    Carenfelt C; Melen I; Odkvist L; Olsson O; Prellner K; Rudblad S; Savolainen S; Skaftason S; Sorri M; Synnerstad B
    Acta Otolaryngol; 1990; 110(1-2):128-35. PubMed ID: 2201163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fundamental and clinical studies on cefixime in pediatrics].
    Iwai N; Shibata M; Mizoguchi F; Nakamura H; Katayama M
    Jpn J Antibiot; 1986 Apr; 39(4):1087-105. PubMed ID: 3761539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Summary of laboratory studies on the antibacterial activity of cefaclor.
    Preston DA
    Infection; 1979; 7 Suppl 6():557-61. PubMed ID: 45088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In vitro comparative effect of cefixime and 7 other beta-lactamines against Streptococcus pneumoniae].
    Boussougant Y; Weber P
    Presse Med; 1989 Oct; 18(32):1553-5. PubMed ID: 2530530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of Ro 15-8074 and Ro 19-5247 in comparison to cefaclor and cefalexin.
    Simon C
    Infection; 1987; 15(2):122-4. PubMed ID: 3596808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.